Optimizing Patient-Centered Lung Cancer Screening: Insights from the MyLungHealth Randomized Clinical Trial

MedXY Editorial Team•Dec 28, 2025•Clinical Updates

Integration of the MyLungHealth patient portal tool with clinician-facing decision support doubled the identification of patients newly eligible for lung cancer screening (4.7% vs 2.3%).
The multi-center pragmatic trial involving over 31,000 participants demonstrated a statistically significant increase in low-dose CT (LDCT) ordering rates through personalized education.
Direct-to-patient data collection effectively addressed critical electronic health record (EHR) gaps regarding smoking duration and cessation dates.
While relative improvements were substantial (aOR 2.19 for eligibility), absolute increases remained modest, suggesting a need for more intensive implementation strategies.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Integration of the MyLungHealth patient portal tool with clinician-facing decision support doubled the identification of patients newly eligible for lung cancer screening (4.7% vs 2.3%).
The multi-center pragmatic trial involving over 31,000 participants demonstrated a statistically significant increase in low-dose CT (LDCT) ordering rates through personalized education.
Direct-to-patient data collection effectively addressed critical electronic health record (EHR) gaps regarding smoking duration and cessation dates.
While relative improvements were substantial (aOR 2.19 for eligibility), absolute increases remained modest, suggesting a need for more intensive implementation strategies.